1. Topsy-turvy stocks: The volatility of the past few trading days could continue into Wednesday.
U.S. stock futures are moving down, indicating all the major indexes could drop by about 1% at the open.
Meanwhile, European markets are in recovery mode after falling by 2% to 3% on Tuesday.
News that German Chancellor Angela Merkel had struck a deal with her center-left rivals to form a coalition government could be supporting market sentiment. The breakthrough follows four months of uncertainty.
Asian markets ended with mixed results. The Shanghai Composite dropped by 1.8% on Wednesday. It’s lost as much as 8% since a recent peak in late January.
On Tuesday, after a gut-wrenching drop in the morning, U.S. markets staged a big recovery. The Dow Jones industrial average closed with a 2.3% gain, while the S&P 500 rose 1.7% and the Nasdaq surged by 2.1%.
2. Wynn steps down: Steve Wynn has stepped down as CEO of Wynn Resorts after allegations of sexual misconduct piled pressure on the billionaire casino mogul and sent the company’s stock tumbling.
Top 5 Casino Stocks To Watch Right Now: Jazz Pharmaceuticals Inc.(JAZZ)
- [By Jim Robertson]
The earnings report summarized the following recent milestones:
The formation of a Scientific Advisory Board (SAB) to provide expert guidance and insight as the Company advances towards product commercialization. in October, Pfenex announced the hiring of Steven Sandoval as Chief Manufacturing Officer.Steven has over 25 years of commercial biopharmaceutical engineering and operations experience, specializing in commercial operations, facility design and licensure of large scale biopharmaceutical commercial manufacturing facilities. Following the announcement in August of the positive Phase 1 trial data for Pfenex’s recombinant anthrax vaccine, discussions with BARDA have been progressing. Pfenex anticipates initiating the PF708 pivotal clinical program by year end. Pfenex entered into a collaboration with Jazz Pharmaceuticals plc (NASDAQ: JAZZ) on multiple hematology/oncology product candidates in July. Regulatory feedback for PF529, Pfenex’s biosimilar candidate to Neulasta (pegfilgrastim), is expected by the end of 2016 and following that feedback, the development path and potential timeline will be outlined.
Do you like this trading idea and want more trading setups delivered to you every day? Consider investing in a subscription to our SmallCap Network Elite Opportunity (SCN EO) portfolio newsletter or our Under the Radar Movers newsletter where you’ll get more and even better trading setups, investing ideas or tips.
- [By Ben Levisohn]
Jazz Pharmaceuticals (JAZZ) has jumped 6.3% to $149.45 after settling a patent dispute.
CarMax (KMX) gained 2.4% to $58 after beating earnings and sales forecasts.
- [By Keith Speights]
In December, I included Jazz Pharmaceuticals (NASDAQ:JAZZ) in a list of the three top healthcare stocks investors were overlooking. At that time, I noted that the biotech stock could be a diamond in the rough with its promising pipeline and low valuation.
- [By Lisa Levin] Gainers
Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
- [By Teresa Rivas]
Jazz Pharmaceuticals (JAZZ) is trading up nearly 9% Thursday, thanks to its settlement with Hikma Pharmaceuticals over the firms patent dispute.
As part of the agreement, Hikma will get to sell a generic version of the drug in question, narcolepsy treatment Xyrem, in 2023, for up to five years, while Jazz will get royalties on those sales.
Janney Montgomery Scotts Ken Trbovich upgraded the shares from Neutral to Buy on the news, and also increased his price target from $138 to $175. From his note:
While this comes about three years earlier than previous settlements with other generic filers, it eliminates the risk of an earlier launch. Six months thereafter Hikma may launch its own generic and others may potentially be able to launch as well. Importantly, Jazz will receive a meaningful royalty on sales, retain the right to launch its own AG, and can authorize other AGs after the initial 6-month Hikma period.
Jazz shares are up 8.9% to $153.2o at recent check.
- [By Benzinga News Desk]
On Wednesday, just 24 hours after Amazon announced its first major sports deal — tying up with the NFL to stream 10 Thursday night games — Alphabet Inc (NASDAQ: GOOGL) laid claim to viewers’ credit cards by debuting YouTube TV, a bundle of 50 major television channels for $35 per month: Link
March 2017 US Challenger layoffs report 43,310 vs 36,975
Initial Jobless Claims for Mar 31 234.0K vs 250.0K estimate; Continuing Claims for Mar 24 2.03M vs 2.04M estimate.
San Francisco Federal Reserve Bank President John Williams is set to speak in Frankfurt at 9:30 a.m. ET.
The Energy Information Administration’s weekly report on natural gas stocks is schedule for release at 10:30 a.m. ET.
Data on money supply for the recent week will be released at 4:30 p.m. ET.
Goldman Sachs initiated Advanced Micro Devices (NASDAQ: AMD) at Sell
JMP Securities upgraded NetApp (NASDAQ: NTAP) from Market Underperform to Market Perform
PiperJaffray upgraded Abiomed (NASDAQ: ABMD) from Neutral to Overweight
Deutsche Bank downgraded T-Mobile (NASDAQ: TMUS) from Buy to Hold
Mizuho downgraded Jazz Pharmaceuticals (NASDAQ: JAZZ) from Buy to Neutral
This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email firstname.lastname@example.org.
Top 5 Casino Stocks To Watch Right Now: Neuralstem, Inc.(CUR)
- [By Lisa Levin]
Shares of Neuralstem, Inc. (NYSE: CUR) were down 29 percent to $1.75. Neuralstem reported the pricing of public offering of common stock and warrants.
- [By William Romov]
Last Wednesday (Dec. 6), the company received a patent for certain methods of production of its phase 2 antidepressant, AV-101.
Penny Stock Current Share Price Dec. 4 – Dec. 8 Gain (as of Dec. 8)
VistaGen Therapeutics Inc. (Nasdaq: VTGN) $1.80 135%
FXCM Inc. (Nasdaq: GLBR) $1.12 124%
Neuralstem Inc. (Nasdaq: CUR) $2.00 75.44%
Ohr Pharmaceuticals Inc. (Nasdaq: OHRP) $1.49 75.29%
ClearSign Combustion Corp. (Nasdaq: CLIR) $3.50 53.85%
Astrotech Corp. (Nasdaq: ASTC) $4.21 51.99%
Burcon NutraScience Corp. (Nasdaq: BUR) $0.72 44%
LM Funding America Inc. (Nasdaq: LMFA) $3.72 42.53%
Second Sight Medical Products Inc. (Nasdaq: EYES) $1.75 42.28%
Globus Maritime Ltd. (Nasdaq: GLBS) $1.47 41.35%
As a result, its share price shot up from $0.92 to $2.52 on Wednesday. The stock pulled back to $1.80 by the end of the week, for a total gain of 135% for the week.
Top 5 Casino Stocks To Watch Right Now: Nemaska Lithium Inc. (NMKEF)
- [By SEEKINGALPHA.COM]
Joe is a fan of Australian-listed Galaxy Resources (GXY on the ASX), acompany with a hard-rock operation in production in Australia, a world-class brine development project (Sal de Vida) in Argentina that has a bank feasibility study on it, and a promising exploration project in Quebec, Canada, near Nemaska’s (OTCQX:NMKEF) Whabouchi project. GXY is up 60% in just the past three months.
- [By SEEKINGALPHA.COM]
Nemaska Lithium (OTCQX:NMKEF) has successfully commissioned the electrolysis cell of its Phase 1 plant in Shawinigan. More heavy lifting will be necessary before the lithium miner will be able to report successful processing of ore from its Whabouchi mine, but boxes are certainly ticked by this company.
- [By SEEKINGALPHA.COM]
Nemaska Lithium (OTCQX:NMKEF) provided a project update and announced a C$50 million bought deal with shares selling for C$1.05 a piece. The fresh funds will be put to work at the Whabouchi development project, which appears to be progressing well. Commercial-scale production is expected by Q1 2019.
Top 5 Casino Stocks To Watch Right Now: GTT Communications, Inc.(GTT)
- [By ]
GTT Communications (GTT) : “I think they have a great business model. I say buy, buy, buy.”
Steel Dynamics (STLD) : “That’s a great steel company and the only one I’ll recommend other than Nucor (NUE) .”
- [By ]
In the Lightning Round, Cramer was bullish on GTT Communications (GTT) , Steel Dynamics (STLD) , Nucor (NUE) , Marriott International (MAR) , MGM Resorts (MGM) and Twitter (TWTR) .
Top 5 Casino Stocks To Watch Right Now: Unifi, Inc.(UFI)
- [By Lisa Levin]
Unifi, Inc. (NYSE: UFI) shares were also up, gaining 18 percent to $26.92 as the company announced Q3 earnings of $0.56 per share on revenue of $161.3 million.